4.6 Article

Real-world clinical, psychosocial and economic burden of atopic dermatitis: Results from a multicountry study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Dermatology

Global Guidelines in Dermatology Mapping Project (GUIDEMAP), a systematic review of atopic dermatitis clinical practice guidelines: are they clear, unbiased, trustworthy and evidence based (CUTE)?

Bernd W. M. Arents et al.

Summary: Many clinical practice guidelines (CPGs) for atopic dermatitis (AD) are not clear, unbiased, trustworthy or evidence-based (CUTE), and there is a need for improvement. The use of the AGREE II instrument is recommended to enhance the quality of CPGs, and improvements in transparency, applicability, evidence foundation, and management of conflicts of interest are necessary.

BRITISH JOURNAL OF DERMATOLOGY (2022)

Article Dermatology

Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study

Marjolein de Bruin-Weller et al.

Summary: The EUROSTAD study enrolled 308 adult patients with moderate-to-severe AD, with an average age of 37 years and a disease duration of 25 years. Most patients used systemic therapy and experienced high disease severity and burden, as well as borderline or clinical levels of anxiety and/or depression.

JOURNAL OF DERMATOLOGICAL TREATMENT (2021)

Article Dermatology

Patient-Reported Disease Burden and Unmet Therapeutic Needs in Atopic Dermatitis

Elizabeth D. Bacci et al.

Summary: This study investigated the symptoms and flare characteristics of AD patients, revealing that most patients experience flares and worsening symptoms during flares. The frequency, duration, and severity of flares increase with greater disease severity and lack of disease control.

JOURNAL OF DRUGS IN DERMATOLOGY (2021)

Article Dermatology

Clinical and Economic Burden of Mild-to-Moderate Atopic Dermatitis in the UK: A Propensity-Score-Matched Case-Control Study

Farah Toron et al.

Summary: The study aimed to assess the clinical and economic burden of mild-to-moderate atopic dermatitis (AD) in the United Kingdom, finding that patients with mild-to-moderate AD had higher comorbidity burden, healthcare resource usage, and costs compared to matched non-AD controls. The country-based economic burden in the UK was high, partly due to the high prevalence of the disease, and productivity burden and comorbidities significantly impacted the economic burden, emphasizing the importance of optimal disease management.

DERMATOLOGY AND THERAPY (2021)

Article Dermatology

The patient-reported disease burden in adults with atopic dermatitis: a cross-sectional study in Europe and Canada

M. de Bruin-Weller et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)

Article Medicine, General & Internal

Atopic dermatitis

Sinéad M Langan et al.

LANCET (2020)

Review Dermatology

Burden of atopic dermatitis in Asia

Tsen-Fang Tsai et al.

JOURNAL OF DERMATOLOGY (2019)

Review Dermatology

A comparison of international management guidelines for atopic dermatitis

Lindsey M. LePoidevin et al.

PEDIATRIC DERMATOLOGY (2019)

Letter Dermatology

Differential disease burden and treatment patterns among adults with psoriasis and atopic dermatitis seen in hospital vs. private clinics

A. Egeberg et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)

Article Dermatology

Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: partII

A. Wollenberg et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)

Article Dermatology

Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults

Eric L. Simpson et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)